Postdoc: Retinal Genomics for Usher Syndrome & Therapeutics

Massachusetts Eye and Ear Infirmary - MEI; Boston (MA); On-site; USD 72,000 - 74,000; Full time

Job summary

Massachusetts Eye and Ear Infirmary in Boston is seeking a highly motivated postdoctoral fellow to lead retinal biology research in the Indzhykulian Laboratory, collaborating with Mass Eye and Ear, Harvard Medical School and partner centers.

Working under the Principal Investigator, you will analyze single-cell and bulk transcriptomic data, design targeted validation experiments, and contribute to manuscripts advancing therapeutic approaches for Usher syndrome.

Qualifications

• PhD, MD/PhD, or equivalent doctoral degree in neuroscience or related field.
• Experience in retinal biology, vision science, or related areas is desirable.
• Strong analytical, writing, and presentation skills.
• Ability to work independently and in teams.

Responsibilities

• Integrate and critically evaluate retinal gene-expression and transcript/isoform data from multiple laboratories.
• Collaborate with computational teams to analyze single-cell, bulk, and long-read datasets focusing on Usher syndrome genes.
• Compare findings across human retina, organoids, and animal models to select best models for therapy.
• Design targeted validation experiments with collaborating labs (RNAscope, immunofluorescence, imaging).
• Evaluate antibodies and reagents for protein localization studies.
• Coordinate data exchange and maintain an integrated results record across collaboration.

Skills

Postdoctoral research

Statistical analysis

Scientific communication

Team collaboration

Education

PhD or equivalent (neuroscience/vision science/ molecular biology)

Job description

Massachusetts Eye and Ear Infirmary in Boston is seeking a highly motivated postdoctoral fellow to lead retinal biology research in the Indzhykulian Laboratory, collaborating with Mass Eye and Ear, Harvard Medical School and partner centers.

Working under the Principal Investigator, you will analyze single-cell and bulk transcriptomic data, design targeted validation experiments, and contribute to manuscripts advancing therapeutic approaches for Usher syndrome.